Previous 10 | Next 10 |
EMERYVILLE, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, announced that it will host a conference call and webcast at 4:30pm ET on Thursday, August 4, 2022, to...
EMERYVILLE, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced it has entered into an $80 million credit facility with Hercules Capital, Inc. (NYSE...
Gritstone has a proprietary vaccine development platform that discovers neoantigens against viruses and cancer cells. A recent spike after a SARS-CoV-2 vaccine announcement has placed a premium on the stock price. I believe their COVID and cancer vaccine programs will have signifi...
Alithya Group (ALYA) +237%.Avino Silver & Gold Mines (ASM) +132%.Comstock Mining (LODE) +73%.Viela Bio (VIE) +53%.Phunware (PHUN) +50%.Tuscan Holdings Corp. (THCB) +45% as Microvast go public through a merger with the company.First Majestic Silver (AG) +37%.Borqs Technologies (BRQS) ...
Gilead Sciences (GILD) and Gritstone Oncology (GRTS), up 44% premarket have entered into a collaboration, option and license agreement to research and develop a vaccine-based immunotherapy to find a curative treatment for HIV infection. Under the terms of agreement, Gilead will make...
Gilead Sciences, Inc. (Nasdaq: GILD) and Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, today announced that the companies have entered into a collaboration, option and license agr...
Gritstone Oncology (GRTS) files for a mixed shelf offering of up to $690M.The filing does not necessarily indicate that a sale has begun, or will occur in the future.SEC Form S-3Shares are unchanged in after-hours trading.Shares closed up 5.5% to $18.11. For further details see: ...
Gainers: Oxbridge Re (OXBR) +62%.Koss (KOSS) +60%.AIkido Pharma (AIKI) +51%.Vertex Energy (VTNR) +56%.Phunware (PHUN) +45%.Edesa Biotech (EDSA) +33%.CarParts.com (PRTS) +32%.Workhorse Group (WKHS) +30%.Orbital Energy (OEG) +27%.Vir Biotechnology (VIR) +27%.Losers: Express ...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. The Dow Jones and S&P 500 indexes fell slightly on Friday but clawed back from their worst losses, while the Nasdaq edged higher to another record clos...
Gritstone Oncology (NASDAQ: GRTS) started the week as a little-known player in the coronavirus vaccine space. Its shares were trading at less than $10 apiece, and the market value totaled well under $1 billion. And then, in a blink of an eye, all of that changed. Its shares -- and m...
News, Short Squeeze, Breakout and More Instantly...
Gritstone Oncology Inc. Company Name:
GRTS Stock Symbol:
NASDAQ Market:
Gritstone Oncology Inc. Website:
-- Event will feature Dr. Randolph Hecht (Professor, UCLA GI Oncology Program) and Howard Brown (CRC Survivor, Patient and Advocate) -- EMERYVILLE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the...
2024-06-14 13:15:03 ET JMP Securities analyst issues MARKET OUTPERFORM recommendation for GRTS on June 14, 2024 11:01AM ET. The previous analyst recommendation was Market Outperform. GRTS was trading at $0.7575 at issue of the analyst recommendation. The overall analyst ...
2024-05-24 11:30:04 ET B. Riley analyst issues BUY recommendation for GRTS on May 24, 2024 09:31AM ET. The previous analyst recommendation was Buy. GRTS was trading at $0.8039 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...